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ABSTRACT 24 
 25 
Shiga Toxin producing Escherichia coli (STEC) O157:H7 is a recently emerged zoonotic pathogen with 26 
considerable morbidity.  Since the emergence of this serotype in the 1980s, research has focussed 27 
on unravelling the evolutionary events from the E. coli O55:H7 ancestor to the contemporaneous 28 
globally dispersed strains observed today.   In this study the genomes of over one thousand isolates 29 
from both human clinical cases and cattle, spanning the history of STEC O157:H7 in the United 30 
Kingdom were sequenced.  Phylogenetic analysis reveals the ancestry, key acquisition events and 31 
global context of the strains. Dated phylogenies estimate the time to evolution of the most recent 32 
common ancestor of the current circulating global clone to be 175 years ago.  This event was 33 
followed by rapid diversification.  We show the acquisition of specific virulence determinates has 34 
occurred relatively recently and coincides with its recent detection in the human population.  We 35 
used clinical outcome data from 493 cases of STEC O157:H7 to assess the relative risk of severe 36 
disease including HUS from each of the defined clades in the population and show the dramatic 37 
effect Shiga toxin repertoire has on virulence.   We describe two strain replacement events that have 38 
occurred in the cattle population in the United Kingdom over the last 30 years; one resulting in a 39 
highly virulent strain that has accounted for the majority of clinical cases in the United Kingdom over 40 
the last decade.   There is a need to understand the selection pressures maintaining Shiga-toxin 41 
encoding bacteriophages in the ruminant reservoir and the study affirms the requirement for close 42 
surveillance of this pathogen in both ruminant and human populations.   43 
 44 
DATA SUMMARY 45 
 46 
FASTQ sequences were deposited in the NCBI Short Read Archive under the BioProject PRJNA248042 47 
(http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA248042) 48 
Supplementary Table 5 is available at the following git repository 49 
https://github.com/timdallman/phylogenomics_stec.git 50 
I/We confirm all supporting data, code and protocols have been provided within the article or 51 
through supplementary data files.  52 
 53 
 54 
IMPACT STATEMENT 55 
 56 
In this article we analyse over 1000 Shiga Toxin producing Escherichia coli (STEC) O157:H7 genomes 57 
from animal and clinical isolates collected over the past three decades and present for the first time 58 
a comprehensive population structure of STEC O157:H7.  Using phylogenetic methods we have 59 
examined the origin and dispersal of this zoonotic pathogen and show how historical worldwide 60 
dissemination followed by regional expansion in native cattle populations gives rise to the extant 61 
diversity seen today.  By comparing clinical outcome data of nearly 500 human cases we 62 
comprehensively assess the association between phylogenetic grouping, acquisition and loss of 63 
specific subtypes of Shiga toxin and severe disease.   With this analysis we show specific circulating 64 
strains have >5 fold increase risk of severe disease than the ancestral STEC O157:H7 genotype.  65 
Finally we show that recent strain replacement has occurred in Great Britain shaping the diversity of 66 
STEC O157:H7 observed today and introducing a high virulence clone into the British cattle 67 
population. 68 
 69 
 70 
INTRODUCTION 71 
 72 
Shiga Toxin producing Escherichia coli (STEC) O157:H7 is a globally dispersed pathogen that, whilst 73 
generally asymptomatic in its ruminant host, can cause severe outbreaks of gastroenteritis, 74 
haemorrhagic colitis and haemolytic uraemic syndrome in humans (Akashi et al., 1994; Centers for 75 
Disease Control and Prevention (CDC), 2006; Ihekweazu et al., 2012). Contemporary STEC O157:H7 76 
represent a monomorphic clone(Whittam et al., 1988) characterised by particular phenotypic 77 
properties including the inability to ferment sorbitol and produce β-glucuronidase.  Over the course 78 
of its evolution, STEC O157:H7 has acquired several virulence determinants including two types of 79 
Shiga toxins (Stx1 and Stx2) encoded on lambdoid bacteriophages (Scotland et al., 1985), a myriad of 80 
effector proteins(Lai et al., 2013; Tobe et al., 2006) and a virulence plasmid containing genes for a 81 
type II secretion system and a haemolysin (Schmidt et al., 1994).   It is postulated that the current 82 
clone arose with the transfer of the O157 rfb and gnd genes that specify the structure of 83 
lipopolysaccharide side chains that comprise the somatic (O) antigens into a stx2 containing E. coli 84 
O55:H7 strain that had an enhanced capacity for host colonisation mediated by the locus of 85 
enterocyte effacement (LEE) pathogenicity island (Wick et al., 2005).   A step-wise sequence of 86 
events involving the loss of the ability to utilise sorbitol, lysogenisation by an stx1 containing phage 87 
and inactivation of the gene encoding the β-glucuronidase uidA is hypothesised to have given rise to 88 
the currently circulating clone (Feng et al., 1998), with distinct subpopulations formed by less 89 
common non-motile O157:H- strains and strains that retained the ability to express β-glucuronidase. 90 
 91 
Despite high levels of relatedness of the non-sorbitol fermenting, β-glucuronidase negative STEC 92 
O157:H7 strains, it has long been realised that distinct lineages exist within the population.  It is 93 
suggested that these arose from the result of geographic spread of an ancestral clone and 94 
subsequent regional expansion (Kim et al., 2001; Yang et al., 2004).   Identified subpopulations have 95 
also been found to be unequally distributed in the cattle and human populations with lineage I being 96 
more prevalent among human clinical isolates and lineage II more associated with the animal host 97 
(Yang et al., 2004).   Subsequent studies revealed differences between the two lineages including 98 
Stx-encoding bacteriophage (StxΦ) insertion sites (Besser et al., 2007), stx2 expression (Dowd and 99 
Williams, 2008), stress resistance (Lee et al., 2012), as well as lineage specific polymorphisms (Bono 100 
et al., 2007).  Further characterisation of genomic differences between these two lineages identified 101 
an intermediate genogroup termed lineage I/II (Zhang et al., 2007).  To investigate the propensity of 102 
different STEC O157:H7 strains to cause serious illness, further sub-typing schemes have been 103 
developed which sub-divided the population into 9 clades based on single nucleotide polymorphisms 104 
(Manning et al., 2008; Riordan et al., 2008) with clade 8 associated with two large outbreaks of 105 
Haemolytic Uremic Syndrome (HUS) (Manning et al., 2008).  Subsequent in vitro studies showed 106 
varied adherence and virulence factor expression between different clades (Abu-Ali et al., 2010) and 107 
whole genome studies elucidated further potential virulence determinants (Eppinger et al., 2011a).  108 
The use of clade genotyping provided further evidence that the diversity within STEC O157:H7 is 109 
globally distributed (Mellor et al., 2013; Yokoyama et al., 2012). 110 
 111 
Several groups have used the clade description of the STEC O157:H7 population to further speculate 112 
on the evolutionary path that has given rise to the current diversity(Kyle et al., 2012; Leopold et al., 113 
2009; Yokoyama et al., 2012).  The current model suggests that β-glucuronidase positive, non-114 
sorbitol fermenting STEC O157:H7 (clade 9) are ancestral to lineage II and the intermediate lineage 115 
I/II (which overlap with clades 8-5) which themselves are ancestral to lineage I (clades 5-1). The 116 
nature of the paraphyletic evolution of these lineages however remains unknown. 117 
 118 
The United Kingdom (UK) has a comparatively high human infection rate with STEC O157(Chase-119 
Topping et al., 2008) and this has remained relatively constant over the last decade.  In the UK, STEC 120 
O157 strains are subtyped by determining sensitivity to a specific panel of 16 typing phages, a phage 121 
typing scheme developed in Canada and adopted by several European countries(Ahmed et al., 1987; 122 
Khakhria et al., 1990).  Over the last decade in England, Scotland and Wales, phage type (PT) 21/28 123 
strains have been most commonly associated with severe human infection and more recent 124 
research has indicated that these strains are more likely to be associated with high excretion levels 125 
from cattle; known as supershedding(Chase-Topping et al., 2008).  Previously, the most common 126 
phage type in England, Scotland and Wales was PT2 until it decreased year after year from 1998 (see 127 
Figure 1).  The nature of this strain replacement and how PT21/28, PT2 and other common phage 128 
types, such as PT8 and PT32 are associated with each other and to the lineages defined above was 129 
not understood. In this study we present the population structure of STEC O157:H7 from a UK 130 
perspective using genome sequencing of over 1000 animal and clinical isolates collected over the 131 
past three decades.  Using phylogenetic methods we have examined the origin and dispersal of this 132 
zoonotic pathogen and estimated approximate evolutionary timescales that have led to the 133 
emergence of an expanded virulent cluster that accounts for a significant proportion of the human 134 
STEC disease in the UK. 135 
 136 
 137 
 138 
 139 
 140 
METHODS 141 
 142 
Strain Selection 143 
 144 
1075 strains of STEC O157 from clinical and animal isolates from England, Northern Ireland, Wales & 145 
Scotland collected from 1985 to 2014 were selected for sequencing.  These represented 25 phage 146 
types. Ninety-five cattle strains were STEC O157:H7 isolates selected for sequencing from Scottish 147 
cattle strains collected as part of ‘The Wellcome Foundation International Partnership Research 148 
Award in Veterinary Epidemiology’ (IPRAVE) study on the basis of regional and genotypic diversity. 149 
54 sequences were downloaded from public repositories including the oldest sequenced STEC 150 
O157(Sanjar et al., 2014).   151 
 152 
Genome Sequencing and Sequence Analysis 153 
 154 
Genomic DNA was fragmented and tagged for multiplexing with Nextera XT DNA Sample Preparation 155 
Kits (Illumina) and sequenced at the Animal Laboratories and Plant Health Agency using the Illumina 156 
GAII platform with 2x150bp reads.   Short reads were quality trimmed(Bolger et al., 2014) and 157 
mapped to the reference STEC O157 strain Sakai (Genbank accession BA000007) using BWA-SW(Li 158 
and Durbin, 2010).  The Sequence Alignment Map output from BWA was sorted and indexed to 159 
produce a Binary Alignment Map (BAM) using Samtools(Li et al., 2009).  GATK2(McKenna et al., 160 
2010) was used to create a Variant Call Format (VCF) file from each of the BAMs, which were further 161 
parsed to extract only single nucleotide polymorphism (SNP) positions which were of high quality 162 
(MQ>30, DP>10, GQ>30, Variant Ratio >0.9).  Pseudosequences of polymorphic positions were used 163 
to create maximum likelihood trees using RaxML(Stamatakis, 2014).  Pair-wise SNP distances 164 
between each pseudosequence were calculated. Spades version 2.5.1(Bankevich et al., 2012) was 165 
run using careful mode with kmer sizes 21, 33, 55 and 77 to produce de novo assemblies of the 166 
sequenced paired-end fastq files.  FASTQ sequences were deposited in the NCBI Short Read Archive 167 
under the BioProject PRJNA248042.     168 
 169 
SNP Clustering 170 
 171 
Hierarchical single linkage clustering was performed on the pairwise SNP difference between all 172 
strains at various distance thresholds (Δ250, Δ100, Δ50, Δ25, Δ10, Δ5, Δ0).  The result of the 173 
clustering is a SNP address that can be used to describe the population structure based on clonal 174 
groups.  175 
 176 
Recombination 177 
 178 
Recombination analysis was performed using BRATNEXTGEN(Marttinen et al., 2012).  179 
Representatives from Δ50 SNP clusters were randomly selected and whole genome alignment 180 
produced relative to the reference strain Sakai.  From the proportion of shared ancestry generated 181 
by BRATNEXTGEN the dataset was partitioned into 18 clusters. Recombination between and within 182 
these clusters was calculated over 20 iterations and the significance estimated over 100 replicates.  183 
Detected recombinant segments were deemed significant with a p-value < 0.05.  184 
 185 
 186 
Timed phylogenies 187 
 188 
Timed phylogenies were constructed using BEAST-MCMC. v1.80(Drummond et al., 2012) and after 189 
first confirming a temporal signal using Path-O-Gen(Drummond et al., 2012). Alternative clock 190 
models and population priors were computed and their suitability assessed based on Bayes Factor 191 
(BF) tests.  The highest supported model was a relaxed lognormal clock rate under a constant 192 
population size.  All models were run with a chain length of 1 billion. A maximum clade credibility 193 
tree was constructed using TreeAnnotator v1.75. 194 
 195 
Shiga toxin subtyping 196 
 197 
Shiga toxin subtyping was performed as described by Ashton and colleagues (Ashton et al., 2015). 198 
 199 
Stx-associated bacteriophage insertion (SBI) 200 
 201 
The integration of shiga toxin carrying prophage into the host genome has been characterised into 202 
six target genes: wrbA(Hayashi et al., 2001), which encodes a NADH quinone oxidoreductase; yehV 203 
(Yokoyama et al., 2000), a transcriptional regulator; sbcB (Ohnishi et al., 2002), an exonuclease ; 204 
yecE, a gene of unknown function; the tRNA gene argW(Eppinger et al., 2011a) and Z2577, which 205 
encodes an oxidoreductase.  Intact reference sequences of these genes were obtained and 206 
compared by blastn BLAST(Altschul et al., 1990) against the STEC O157:H7 genome assemblies.  207 
Occupied SBI sites were defined as those strains that had disrupted BLAST alignments.  208 
 209 
Clade Typing 210 
 211 
Clade Typing was performed as originally defined by Manning et al (2008).  The 8 definitive 212 
polymorphic positions adopted by Yokoyama et al (2012) were used to delineate the strains into the 213 
9 clade groupings.  214 
 215 
Locus Specific Polymorphism Assay – LSPA6 216 
 217 
Based on the polymorphic genes defined by Yang et al (2004) reference sequences of 6 were 218 
extracted from the Sakai reference genome.  Sequence alignments were generated using blastn of 219 
these sequences against the STEC O157:H7 genome assemblies. The allelic designation ‘1’ was 220 
assigned to wild type, ‘2’ assigned to the insertions/deletions defined by Yang et al and ‘X’ to all 221 
other polymorphisms.    222 
 223 
folD-sfmA, Z5935, yhcG, rbsB, rtcB and arp-iclR. Each allele was assigned a number as described 224 
previously (Yang et al., 2004). Isolates showing the LSPA6 genotype 111111 were classified as LSPA6 225 
lineage I (LSPA6 LI), while those with LSPA6 genotype 211111 were classified as LSPA6 lineage I/II 226 
(LSPA6 LI/II). Unique alleles (aberrant amplicon size) were assigned new numbers. All deviations 227 
from the genotypes 111111 and 211111 were classified as LSPA6 lineage II (LSPA6 LII).  228 
 229 
Statistical analyses of clinical data amongst clinical cases reported in England  230 
 231 
The National Enhanced Surveillance System for STEC (NESSS) in England was implemented on 1s t 232 
January 2009, and has been described in detail elsewhere (Byrne et al. 2015, in press). In brief, it 233 
collates standardised demographic, clinical and exposure data on all cases of STEC reported in 234 
England through collection of a standard enhanced surveillance questionnaire (ESQ).  For this study, 235 
clinical data on clinical cases for whom strains were sequenced were extracted from NESSS. These 236 
data included whether the case reported symptoms of non-bloody diarrhoea; bloody diarrhoea; 237 
vomiting; nausea; abdominal pain; fever or whether they were asymptomatic carriers detected 238 
through screening high risk contacts of symptomatic cases. Data on whether cases were 239 
hospitalised, developed typical HUS or died were also extracted.  The age and gender of cases were 240 
also extracted. Where clinical symptoms were blank on the ESQ and cases were not recorded as 241 
being asymptomatic, these were coded as negative responses.  Cases were categorised into children 242 
(aged 16 and under) or adults, based on a priori knowledge that children are most at risk of both 243 
STEC infection and progression to HUS (Byrne et al., 2015). While adults aged over 60 are at 244 
increased risk of STEC infection and development of HUS, they were under-represented in these 245 
data and were not analysed as a separate group. The outcome of interest was disease severity. Cases 246 
were coded as having severe disease   if any of the following criteria were reported: Bloody 247 
diarrhoea, hospitalisation, HUS or death. Asymptomatic cases and cases with non-bloody diarrhoea 248 
were classed as mild. 249 
 250 
Genomic variables for analyses included Stx subtype and sublineage. Sublineages were described in 251 
respect of Stx subtypes. Cases were described in respect to clinical mild or severe disease and HUS 252 
separately) by sublineage. Disease severity was compared amongst gender and age of cases, and 253 
sublineage and Fisher’s exact tests were used to compare proportions.  Logistic Regression analysis 254 
was used to investigate phylogenetic groups associated with more severe disease outcomes. Due to 255 
the correlation between Stx subtypes and lineage, sublineage was chosen as an explanatory variable 256 
for analyses. To assess whether there was a difference in disease severity within sub-lineages they 257 
were further subdivided by Stx subtype for analysis. Odds ratios for cases reporting severe disease 258 
compared to those reporting mild disease were calculated for each variable. Lineage IIa was chosen 259 
as the baseline for lineages as it was found to be the ancestral O157 lineage.  260 
 261 
RESULTS 262 
 263 
Phylogeny of STEC O157 in the United Kingdom 264 
 265 
A maximum likelihood (ML) phylogeny (supplementary figure 1) revealed the population structure of 266 
the STEC O157 isolates sequenced in this study.  The STEC O157:H7 population has previously been 267 
delineated into three lineages, I, I/II and II(Feng et al., 1998; Zhang et al., 2007) and the phylogeny 268 
presented here also splits the strains into three groups via deep branches, with reference strains of 269 
known lineage(Eppinger et al., 2011b) conforming to the expected pattern.   270 
 271 
The ML phylogeny was compared to two other previously used methods to describe the STEC O157 272 
population namely LSPA6 type(Yang et al., 2004) (supplementary  figure 1a) and the Manning clade 273 
typing scheme(Manning et al., 2008) (supplementary  figure 1b).   LSPA6 typing was not congruent 274 
with the phylogeny and the lineages defined by LSPA type do not reflect the phylogenetic clustering 275 
generated on polymorphisms across the whole genome.  By LSPA6 the only strains that type as 276 
lineage I (LSPA6 1-1-1-1-1-1) were a clade containing the lineage I strain the assay was designed 277 
upon, EDL933.  Other strains that cluster within this deep branch (and therefore should be of the 278 
same lineage) type as lineage I/II (LSPA6 2-1-1-1-1-1) or had a novel polymorphism.  Similarly across 279 
the rest of the ML phylogeny the predominant LSPA6 was 2-1-1-1-1-1 or a novel polymorphism.  280 
Based on this population, LSPA6 typing did not resolve the lineages correctly and therefore we 281 
defined the lineages I, I/II and II based on the deep phylogenetic branches and the placement of 282 
reference strains of known lineage. 283 
 284 
Supplementary figure 1b shows the phylogeny coloured by clades as described by Manning et al 285 
(2008).  The clade groupings were broadly congruent with the phylogeny clade 7 (green), clade 8 286 
(purple) and clade 4/5 (cyan) predominated and clade 9 (pink), comprising strains that were β-287 
glucuronidase positive, are an out-group.  It was clear however that clade typing does not resolve 288 
many phylogenetic splits.  In terms of clade typing, lineage II corresponds to clade 7, lineage I/II 289 
corresponded to clade 8 and lineage I corresponded to clades 6 through 1 as suggested previously 290 
(Eppinger et al., 2011a). 291 
 292 
Single linkage clustering based on pairwise genetic distance is an effective method of defining 293 
phylogenetic groups as it is inclusive of clonal expansion events.  Using a SNP distance threshold of 294 
Δ250 we clustered the 1224 strains in this study into 54 groups.  52/54 clusters were distributed 295 
within the 3 lineages and there were two outlier clusters, one contained the β-glucuronidase 296 
positive strains and another contained 3 isolates associated with travel to Turkey.  Supplementary 297 
figure 2 shows the number and size of the 52 clusters within the three lineages.  Lineage II contained 298 
the most diversity with 32 clusters whilst Lineage I and Lineage I/II contained 17 and 3 clusters 299 
respectively.  All three lineages were associated with uneven sampling of diversity with single high-300 
density clusters comprising 77% of Lineage I isolates, 73% of Lineage I/II isolates and 47% of Lineage 301 
II isolates. Isolates contained within the high-density clusters in Lineage I, I/II and II represented the 302 
common phage types associated with human infection in the UK: PT21/28, PT2 and PT8 respectively.  303 
Isolates in clusters with five or less representatives were more likely to be non-UK strains associated 304 
with foreign travel or imported food.  Ninety-five isolates were from cattle faecal pats collected as 305 
part of a large survey in Scotland(Pearce et al., 2009). These cattle isolates were present in only 8/54 306 
clusters across the three lineages with 84% found in the 3 high-density clusters identified above.  307 
This pattern of uneven diversity, coupled with the association of domestic cattle with high-density 308 
clones, supports the model of global dispersion and regional expansion of STEC O157:H7.   309 
 310 
Recombination  311 
 312 
Signals of recombination in the sample population were analysed with BRATNEXTGEN using 270 Δ50 313 
SNP threshold cluster representatives.  There were 631,016 recombinant positions found across the 314 
5,498,450 bp alignment and 90% had their origin in the 18 Sakai prophages (SP) or 6 Sakai prophage 315 
like elements (SPLE) suggesting that almost all genetic transfer (at least historical) was phage 316 
mediated.  The median recombinant size was 575 base pairs whilst the largest was 41212 317 
nucleotides representing an intra-lineage II recombination of SP1.  Recombination events were seen 318 
at least twice as frequently within lineages (Supplementary table 1) than between lineages with no 319 
statistical difference association between the lineage and its likelihood to be a donor or recipient. 320 
Within lineage II, the ancestral lineage (see Figure 2) Lineage IIa appeared to be the donor of most 321 
recombination events with lineage IIc only receiving foreign DNA.  Lineage I had the highest intra-322 
lineage recombination rate, and this that could have contributed to the heterogenous stx 323 
complement as described in more detail below. 324 
 325 
Evolutionary timescale and Stx prophage insertion in STEC O157  326 
 327 
A timed phylogeny was constructed using BEAST (Figure 2). The mutation rate of STEC O157:H7 was 328 
calculated to be approximately 2.6 mutations/genome/year (95% highest posterior density (HPD) – 329 
2.4 – 2.8) which is in-line with previous estimates for Escherichia coli(von Mentzer et al., 2014) and 330 
closely related Shigella species(Holt et al., 2012).  We predict the split of the contemporary β-331 
glucuronidase negative, sorbitol negative clone from the β-glucuronidase positive ancestor to be 332 
approximately 400 years ago (95% HPD - 520 years – 301 years).  The time to common ancestor of 333 
the current circulating diversity (e.g. Lineage I, I/II and II) is approximately 175 years (95% HPD - 198 334 
years – 160 years), significantly more recent than previous estimates of 400 years(Yang et al., 2004) 335 
and 2500 years(Leopold et al., 2009).   Lineage II is the ancestral lineage which contains at least three 336 
sub-lineages that diverged early in the evolutionary process.  The most recent common ancestor to 337 
Lineage I and Lineage I/II existed approximately 150 years ago (95% HPD - 175 years – 130 years). 338 
 339 
The model of Shiga toxin acquisition proposed by Wick and Feng suggested the acquisition of a 340 
lambdoid phage containing stx2 followed by the later acquisition of an stx1 containing phage 341 
(Stx1Φ)(Feng et al., 1998; Wick et al., 2005).  The timed phylogeny supported this hypothesis (Figure 342 
2) as the β-glucuronidase positive ancestor and the majority (70%) of stains within lineage IIa and IIb 343 
contained only stx2c.  Sub-lineage Lineage IIc (PT8) (Figure 2) was subsequently lysogenised by an 344 
Stx1Φ and had the same disrupted Shiga toxin insertion targets yehV and sbcA supporting the 345 
hypothesis that a truncated prophage was replaced with a Stx1Φ in yehV(Shaikh and Tarr, 2003). 346 
 347 
The majority of strains in Lineage IIb (PT4/PT1) (Figure 2) carried stx2c only but had an occupied 348 
argW Stx-associated bacteriophage insertion site. There was some further observed heterogeneity 349 
in the ancestral lineage IIa with small numbers of dispersed strains containing Stx1Φ, Stx2Φa or 350 
being negative for any Shiga toxin alleles as well as having non-stx disrupted stx-associated 351 
bacteriophage insertion sites (Supplementary table 2). 352 
 353 
The common ancestor of Lineage I/II (Figure 2) was approximately 95 years old marking the 354 
divergence of the strain that caused the 2006 Taco Bell outbreak in North America (Sodha et al., 355 
2011) and the PT2 strains associated with the first outbreak of HUS in the United Kingdom in 356 
1983(Taylor et al., 1986). The majority (65%) of strains in lineage I/II were positive for both stx2c and 357 
stx2a with occupied SBIs at yehV , sbcA and argW.  One sub group of strains belonging to PT2 have 358 
subsequently lost d an intact sbcA (Supplementary table 3). 359 
 360 
Lineage I was by far the most heterogeneous in terms of Stx complement (Supplementary table 4) 361 
and arose from a stx2c-only ancestor approximately 125 years ago (Figure 2).  The majority (87%) of 362 
strains in Lineage Ib (PT32) retained the ancestral stx2c only genotype of Lineage II and have an 363 
additional yecE SBI occupied.  This lineage had an overrepresentation of strains from Scottish cattle 364 
and very few clinical strains.  The majority (64%) of strains in Lineage Ia contained Stx2aΦ and Stx1Φ 365 
with disrupted yehV and wrbA including the first fully sequenced STEC O157:H7 genomes 366 
(Sakai(Hayashi et al., 2001) and EDL-933(Latif et al., 2014)) and the genome sequence of E. coli 367 
O157:H7 strain 2886-75, which was isolated in 1975 making it the oldest STEC O157:H7 strain for 368 
which a genome sequence is available (Sanjar et al., 2014).  Lineage Ia also contains strains that type 369 
as Clade 6 by the Manning scheme and carry the stx2c and stx2a genes with disrupted yehV and 370 
sbcA which suggests either Stx2aΦ inserted into yehV or a novel insertion site.   371 
 372 
A final sub-lineage of Lineage I (Lineage Ic) contains 40% of the strains in this study and its common 373 
ancestor is approximately 50 years old and has since diverged into 3 clades.  These include the 374 
ancestral stx2c only genotype with occupied yehV and sbcA SBIs, a stx2a only genotype with 375 
occupied yecE, yehV insertion sites and a stx2a and stx2c genotype with occupied SBIs yehV, sbcA 376 
and argW.  This final genotype is predominated by phage type 21/28. Within the PT 21/28 clade a 377 
sub-clade has subsequently lost the stx2c toxin although yehV, sbcA and argW remain occupied.   378 
 379 
All 1129 genomes analysed in this study are summarised in terms of Lineage, SNP cluster, SBI, stx 380 
type, Manning Clade and LSPA-6 type in Supplementary table 5. 381 
 382 
Recent Emergence of Predominant UK Lineages 383 
 384 
The phage types PT8 and PT21/28 accounted for approximately 60% of clinical isolates identified in 385 
the United Kingdom in 2014.  Phage typing of STEC O157:H7 in the UK suggests strain replacement 386 
has occurred since the beginning of the 21s t century with a decline in PT2 corresponding with a rise 387 
in PT21/28.  PT2 was restricted to lineage I/II whereas PT21/28 was restricted to lineage I indicating 388 
strain replacement of one genotype by another distinct genotype, rather than phage type switching 389 
within a single genotype.  390 
 391 
PT 21/28 typically accounts for >30% of clinical isolates seen in the England, Wales and Scotland 392 
each year and is the phage type most commonly associated with outbreaks of HUS(Underwood et 393 
al., 2013).  As stated above, divergence from the most recent common ancestor occurred 50 years 394 
ago subsequently formed into 3 clades; the ancestral PT32 stx2c only genotype, a stx2a only PT32 395 
genotype associated with travel to Ireland and mainland Europe and finally the PT21/28 clade as a 396 
single Δ50 SNP cluster.  The PT21/28 clade contained a large number of British cattle (57% of total 397 
cattle isolates) and clinical isolates but very few isolates associated with foreign travel (<1%).  The 398 
PT21/28 clade arose only 25 years ago and has since undergone a radial expansion resulting in a 399 
“comet” like phylogeny (Figure 3.).  The PT 21/28 clade itself was flanked by three PT32 stx2a and 400 
stx2c isolates, two from cattle and one clinical isolate from Scotland.  It is clear that the direct 401 
ancestor of PT21/28 is a PT32 strain. 402 
 403 
PT8 was represented as a single Δ250 SNP clonal group (lineage IIc) and its most recent common 404 
ancestor can be dated to approximately 50 years ago.  Across this clonal group cases were 405 
associated with travel to Southern Europe and Northern Africa (22%) suggesting this strain may be 406 
endemic in cattle in this region.  Within this group there was a recently emerged (30 years to most 407 
recent common ancestor) sub-clade where several cases report exposure to domestic cattle, cases 408 
report no foreign travel, and there are several strains from UK cattle suggestive of a domestic source 409 
of human infection (Figure 4).  This again highlights the possibility of imported strains of O157:H7 410 
becoming endemic in local cattle populations. 411 
 412 
Disease severity of clinical cases in England by stx subtype and sublineage 413 
 414 
A total of 493 strains from clinical cases in England had clinical data available in NESSS. Of those, 311 415 
(63.1%) had experienced bloody diarrhoea, 158 (32.0%) had been hospitalised with their illness and 416 
26 (5.3%) were from cases known to have developed HUS. Thus, two thirds of cases in the dataset 417 
were categorised as having severe disease (as defined in methods) however this varied by stx 418 
subtype and sub-lineage (Table 1). Cases classed as having mild disease accounted for 33.5% of the 419 
dataset, and included eighteen asymptomatic cases. Over half (55.4%) of cases in the dataset were 420 
female and 55.2% were children aged 16 and under. Severe disease was more frequently reported 421 
amongst females (70.3% versus 29.7%, p=0.044) and children (71.9% versus 28.1%, p=0.005). 422 
 423 
In univariable analysis, being a child and being female were significantly associated with severe 424 
disease (Table 2).All sublineages except Ib and Ic carrying stx2c, were significantly associated with 425 
more severe disease  as compared to sublineage IIa.  In the final multivariable model when all 426 
variables were controlled for, being a child was a significant predictor of severe disease, but being 427 
female was no longer significant. Sub-lineage Ia had the greatest odds of severe disease, with a six-428 
fold increased odds as compared to IIa.  429 
 430 
All but one of the HUS cases fell within sub-lineages I-c and I/II (Figure 1) and all were infected with 431 
strains carrying stx2a either alone or with stx2c (Table 2). Lineages Ic and I/II were further divided 432 
into strains possessing stx2a only and those with stx2a/2c. Across all strains, there was no difference 433 
in disease severity between cases infected with strains carrying stx2a alone or with 2c (53.5% versus 434 
46.5%, p=0.291).  However, in both sublineages Ic and I/II strains carrying stx2a only had higher odds 435 
of severe disease than those carrying stx2a/2c in the final model.  While Sub-lineage IIc had 436 
increased odds of severe disease, no cases developed HUS. Rather this was due to increased 437 
reporting of bloody diarrhoea amongst cases infected with these strains compared to those in other 438 
sub-lineages (75.6-% versus 58.6% in other sub-lineages, p=0.005). Most strains (92%) in this sub-439 
lineage carried stx1a/2c. Overall, cases infected with strains carrying stx1a reported bloody 440 
diarrhoea more frequently than those without (77.5% versus 61.8%, p=0.001) leading to the 441 
hypothesis the possession of stx1a in strains of sublineage IIc leads to higher rates of bloody 442 
diarrhoea. 443 
 444 
 445 
DISCUSSION 446 
 447 
Using phylogenetic analysis of variation at the whole genome level we have been able to reconstruct 448 
the phylogenetic history and global diversification of the contemporary STEC O157:H7 clones.  The 449 
current models of STEC O157:H7 evolution suggest the sero-conversion of an ancestral stx2 E. coli 450 
O55 to O157.  Subsequent loss of the ability to ferment sorbitol and of β-glucuronidase activity gave 451 
rise to the common ancestor of the current circulating clone.    The evolutionary models of Leopold 452 
et al. ( 2009), Kyle et al.(2012) and Yokoyama et al.( 2012) suggest that the β-glucuronidase positive 453 
last common ancestor may have given rise to lineage II and lineage I/II in a paraphyletic manner with 454 
lineage I/II spawning lineage I (with the acquisition of Stx1 containing lambdoid phage seen in clades 455 
1-3 described by Manning et al. 2008).  However, strains had previously been identified that 456 
confounded these models and indicated that a more complex explanation was needed (Arthur et al., 457 
2013; Mellor et al., 2013).  458 
 459 
In this study we propose a new evolutionary model based on our phylogenetic analysis (Figure 5).  In 460 
this model we maintain the stepwise series of events from STEC O55 to the β-glucuronidase positive 461 
last common ancestor (A5) that evolved into contemporary lineage II.   We show at least 3 extant 462 
lineages of lineage II including the ancestral branch (IIa) as well as a branch that has acquired Stx1Φ 463 
(IIc).  A lineage II Stx2cΦ containing strain independently gave rise to Lineage I (approximately 125 464 
years ago) and Lineage I/II (approximately 95 years ago).  In lineage I/II a single integration event of a 465 
Stx2aΦ into argW has been maintained with a sub-group losing Stx2cΦ.  Lineage I has a more 466 
to wrbA, once into 467 
argW, and once into an unknown site), Stx1Φ inserting into lineage Ia strains and at least two loss 468 
469 
fixed in the population but we also observe many loss and gain events that appear to be occurring 470 
sporadically within each lineage as well as occupation of SBI’s with imported DNA that does not 471 
encode Stx.  This leads to the conclusion that the loss and gain of phage is likely to be highly dynamic 472 
but under high selection for retention in the bovine host.  Recombination analysis highlighted the 473 
phage regions to be hotspots of DNA exchange, with remarkably little activity outside these regions.  474 
 475 
In this analysis we predict the split from the β-glucuronidase positive last common ancestor (A5) to 476 
have occurred approximately 400 years ago with the common ancestor of the current diversity 477 
appearing 175 years ago.  At this point there was an expansion event with the major lineages formed 478 
within 30 or so years.  This early diversification of STEC O157:H7 fits with the extant diversity of STEC 479 
O157:H7 being globally distributed. Although a large degree of diversity of STEC O157:H7 is seen in 480 
the UK, the distribution of this diversity is uneven.  We show that several pockets of diversity are 481 
seen at much higher frequency then others and that the same pockets of diversity are more 482 
frequently observed in both human clinical cases and in the local cattle population.  This fits with 483 
model of historical dissemination of diversity and then regional expansion in native cattle with 484 
occasional sampling of the wider diversity through imported foodstuff and foreign travel.  485 
 486 
Although we have shown the contemporary clone existed over 100 years earlier, STEC O157:H7 only 487 
became a recognised pathogen in the 1980’s(Riley et al., 1983) after causing outbreaks of severe 488 
illness.  Whilst STEC O157:H7 causes gastroenteritis in most infections a significant minority develop 489 
more severe symptoms including HUS.  Whilst progression to HUS no doubt has many host 490 
predictors, a clear association with the presence of stx2a subtype has been shown(Persson et al., 491 
2007). In our study we show that the acquisition of the stx2a subtype occurred relatively recently 492 
compared to the other stx subtypes and is likely to explain the recent emergence of the STEC 493 
O157:H7 serotype as a clinically significant pathogen.  We also show that stx2a is likely to have been 494 
acquired by STEC O157:H7 on multiple occasions highlighting the potential for new, highly virulent 495 
clones to emerge. Finally it appears that once stx2a is integrated in a population it tends to be 496 
maintained, often at the expense of stx2c.  Recent re497 
associated not only with more severe human disease but also with higher excretion levels in 498 
cattle(Matthews et al., 2013). 499 
 500 
Using clinical outcome data on a cohort of nearly 500 STEC O157:H7 cases we are able to assess the 501 
risk of serve disease of each of the extant lineages and sub-lineages.  The presence of stx2a is a pre-502 
requisite for the development of HUS with 100% of HUS cases infected with a strain harbouring this 503 
toxin sub-type.  Multivariable regression analysis with the ancestral IIa clone as the baseline shows 504 
IIc has a nearly 4-fold increase in risk of severe disease accounted by in increase in incidence of 505 
bloody diarrhea.  This PT8 clone has acquired a Stx1Φ carrying the same Stx as found in Shigella 506 
dysenteriae serotype 1.  All sub-lineages of lineage I and I/II that contain stx2a have an increased risk 507 
of severe disease with the additional presence of stx2c appearing to have a protective effect.  This 508 
presumably reflects regulatory interactions between the prophages. These analyses show the clear 509 
importance of determining the Stx complement of an STEC O157 strain when predicting the likely 510 
risk of severe disease and therefore case management.  511 
 512 
This study shows that recent strain replacement has occurred in Great Britain shaping the diversity 513 
of STEC O157:H7 observed today.  Within lineage II, an importation of a PT8 strain probably from the 514 
Mediterranean cattle population of Southern Europe and Northern Africa occurred within the last 30 515 
years.  Similarly within the last 25 years the emergence and rapid expansion of PT 21/28 in lineage I 516 
in Great Britain led to this highly virulent subtype being found ubiquitously in domestic cattle.  These 517 
recent strain replacement events provide insight into the dynamics of STEC O157:H7 transmission on 518 
a national and international scale and suggest that while the overall diversity of this pathogen is 519 
globally distributed, regionally endemic strains can be transmitted and eventually become the 520 
dominant strain in the local cattle population.  Whilst the imported strain may play a role in out-521 
competing domestic strains, agricultural practices such as culling and restocking of animals, as seen 522 
during the foot and mouth disease and Bovine Spongiform Encephalitis (BSE) epidemics may act as 523 
drivers facilitating more rapid strain replacement (Carrique-Mas et al., 2008). 524 
 525 
From the current study it appears the relatively high incidence of STEC O157 human infections in the 526 
UK results from the emergence and expansion of a Lineage I PT21/28 clade in the last 25 years, 527 
producing strains containing both Stx2a and Stx2c prophages that are capable of higher excretion 528 
levels from cattle (super-shedding) and can cause severe disease in humans.  Therefore, screening 529 
and intervention strategies should be targeting these strain clusters that are the most significant 530 
threat to human health.  Further work is needed to understand the diversity of host phages that 531 
carry Stx and the reasons behind the proliferation of this cluster.  While Stx is essential for the severe 532 
pathology associated with human STEC disease, the role of the different toxins in governing 533 
supershedding is unknown.  Moreover, it is evident that other genes on Stx-encoding prophages 534 
regulate the expression of bacterial colonisation factors and this will also impact on the success of 535 
the cluster(Xu et al., 2012).  536 
 537 
 538 
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FIGURES AND TABLES 756 
 757 
Figure 1.  Proportion of cases of the predominant phage types in England & Wales and Scotland over 758 
the last 20 years. 759 
 760 
Figure 2. Maximum clade credibility tree of 530 Δ25 SNP representatives.  The tree is highlighted by 761 
lineage and the loss and gain of StxΦ with the associated Stx-associated bacteriophage insertion 762 
(SBI) in brackets.  The GUD+ lineage represents the strains that retained the ability to express β-763 
glucuronidase. 764 
 765 
Figure 3.  Left - maximum likelihood phylogeny of 400 lineage I Δ5 SNP representatives with lineage 766 
Ic highlighted in grey. Right – maximum likelihood phylogeny of lineage Ic showing the radial 767 
expansion of PT21/28 from the PT32 ancestor with isolates annotated by cattle or clinical origin. 768 
 769 
Figure 4.  Left - maximum likelihood phylogeny of 241 lineage II Δ5 SNP representatives with lineage 770 
IIc (PT8) highlighted in grey.   Right – maximum likelihood phylogeny of lineage IIc showing the 771 
distribution of Mediterranean travel associated cases and UK cattle cases. 772 
 773 
Figure 5.  STEC O157:H7 evolutionary model based on a timed phylogeny of over 1000 genomes 774 
showing the key evolutionary splits and the associated gain and loss of stx containing prophage. 775 
GUD+ represents strains that have the ability to express β-glucuronidase, sor+ represents strains 776 
that have the ability to ferment sorbital. 777 
 778 
 779 
Sublineage 
Mild Severe1 Totals %HUS2 
n % n % n % n % 
II a 42 56.8 32 43.2 74 100 1 1.4% 
II b 18 81.8 4 18.2 22 100 0 0.0% 
II c 31 23.7 100 76.3 131 100 1 0.8% 
I a 3 17.7 14 82.3 17 100 0 0.0% 
I b 7 77.8 2 22.2 9 100 0 0.0% 
Ic (stx2a) 9 20.9 34 79.1 43 100 8 18.6% 
Ic (stx 2a/2c) 35 30.2 81 69.8 116 100 10 8.6% 
Ic (stx2c) 1 25 3 75.0 4 100 0 0.0% 
I/II (stx2a) 7 18.4 31 81.6 38 100 2 5.3% 
I/II (stx2a/2c) 12 30.8 27 69.2 39 100 4 10.3% 
All strains 165 33.5 328 66.5 493 100 26 5.3% 
 780 
Table 1: 781 
Sub-lineage and stx subtype of whole genome sequenced strains isolated from clinical cases of STEC 782 
O157 in England. 1Includes cases with bloody diarrhoea or cases who were hospitalised.  2The 783 
lineage IIa strain isolated from a patient with HUS possessed stx2a/2c; The lineage IIc strain 784 
possessed stx1a/2a/2c. 785 
 786 
 787 
 788 
 789 
 790 
Univariable  
Variable Category Odds Ratio P-value Lower 
95% CI 
Upper 95% CI 
Age Child 1.73 0.005 1.18 2.51 
Adult Baseline 
Sex Female 1.49 0.037 1.02 2.17 
Male Baseline 
Sub 
lineage 
II a Baseline 
II b 0.29 0.040 0.09 0.95 
II c 4.23 0.000 2.30 7.80 
I a 6.12 0.008 1.62 23.14 
I b 0.37 0.240 0.07 1.93 
Ic (stx2a) 4.96 <0.001 2.08 11.80 
Ic (stx2a/2c) 2.92 0.001 1.59 5.34 
Ic (stx2c) 3.94 0.245 0.39 39.65 
I/II (stx2a) 5.81 <0.001 2.27 14.88 
I/II (stx2a/2c) 2.95 0.010 1.30 6.71 
Multivariable Analysis   
Variable Category Odds Ratio P-value Lower 
95% CI 
Upper 95% CI 
Age Child 1.56 0.042 1.01 2.39 
Adult Baseline 
Sex Female 1.15 0.489 0.76 1.75 
Male Baseline 
Sub 
lineage 
II a Baseline 
II b 0.29 0.040 0.09 0.95 
II c 3.65 <0.001 1.95 6.83 
I a 6.09 0.008 1.60 23.20 
I b 0.35 0.209 0.67 1.81 
Ic (stx2a) 5.05 <0.001 2.11 12.10 
Ic (stx2a/2c) 3.06 <0.001 1.66 5.67 
Ic (stx2c) 3.48 0.293 0.34 35.62 
I/II (stx2a) 4.89 0.001 1.88 12.73 
I/II stx(stx2a/2c) 2.87 0.012 1.26 6.58 
 791 
Table 2: 792 
Disease severity amongst clinical cases of STEC O157 in England where strains had been whole 793 
genome sequenced by age, gender and sublineage. 794 
 795 
 796 
 797 
